Back to companies
MoonLake Immunotherapeutics
MLTXCHNASDAQPharmaceuticals & HealthcareMoonLake Immunotherapeutics
Revenue
—
FY2025
Operating income
-$244.8mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API